What is Repligen's SG&A?

Repligen (RGEN) reported SG&A of $76.54M in Q1 2026.

How has Repligen's SG&A changed year-over-year?

Repligen's SG&A increased by 8.2% year-over-year, from $70.71M to $76.54M.

What is the long-term trend for Repligen's SG&A?

Over 2 years (2021 to 2023), Repligen's SG&A has grown at a 9.0% compound annual growth rate (CAGR), from $183.87M to $218.35M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Repligen RGEN SG&A

SG&A at other companies

TEC

Bio-TechneTECH

$109.34M-27.7%

RevvityRVTY

$253.88M+1.7%

Thermo Fisher ScientificTMO

$2.18B+5.0%

DanaherDHR

$1.86B+0.1%

Agilent TechnologiesA

$465M+2.4%

Bio-Rad LaboratoriesBIO

$212.4M+1.7%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's SG&A?: Repligen (RGEN) reported SG&A of $76.54M in Q1 2026.
How has Repligen's SG&A changed year-over-year?: Repligen's SG&A increased by 8.2% year-over-year, from $70.71M to $76.54M.
What is the long-term trend for Repligen's SG&A?: Over 2 years (2021 to 2023), Repligen's SG&A has grown at a 9.0% compound annual growth rate (CAGR), from $183.87M to $218.35M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.